.avif)
.avif)
Ironwood Pharmaceuticals Email Format
Biotechnology Research
・
201-500 employees
・
Boston, MA, USA
Ironwood Pharmaceuticals is a biotechnology company focused on advancing the treatment of gastrointestinal diseases, including market-leading therapies for IBS-C and CIC.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@ironwoodpharma.com
Company Overview
Industry
Biotechnology Research
Founded
1998
Headquarters
Boston, MA, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Website
Key Executives
Thomas McCourt (Chief Executive Officer), Ronald Silver (interim chief financial officer and principal financial officer), Rob Drew (Interim Chief Information Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals uses the firstinitiallast format, so Jane Smith would be jsmith@ironwoodpharma.com.
What is the flagship commercial product that Ironwood Pharmaceuticals co-promotes with AbbVie?
LINZESS (linaclotide) is Ironwood Pharmaceuticals' flagship product, co-commercialized with AbbVie and prescribed for irritable bowel syndrome with constipation and chronic idiopathic constipation. In Q1 2026, LINZESS U.S. net sales reached $272.5 million, a 97% year-over-year increase.
What gastrointestinal condition is Ironwood Pharmaceuticals targeting with its apraglutide pipeline program?
Ironwood Pharmaceuticals is developing apraglutide, a once-weekly GLP-2 analog, for Short Bowel Syndrome with Intestinal Failure (SBS-IF), a severe condition affecting roughly 18,000 adult patients across the U.S., Europe, and Japan. A Phase 3 confirmatory trial called STARS-2 was initiated in 2026.
How many employees does Ironwood Pharmaceuticals have?
Ironwood Pharmaceuticals has approximately 262 employees. You can use Clay to build a targeted list of Ironwood Pharmaceuticals contacts and verify their email addresses using the firstinitiallast format on ironwoodpharma.com.
Who is the CEO of Ironwood Pharmaceuticals?
Thomas McCourt serves as Chief Executive Officer of Ironwood Pharmaceuticals. The company, headquartered in Boston, MA, focuses on gastrointestinal health and operates as a publicly traded biotechnology company on Nasdaq under the ticker IRWD.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating